Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Ranking
By Turnover
(€3.3 billion)- 26th in Top Companies
By Employees
(120)- 667th in Top Companies
- 120
- €3.3 billion
Employees
- David Keenan Vice President}